
Life
FDA approves Lembaz for infantile-onset Niemann-Pick disease
The FDA approved the treatment to reduce mortality in patients whose neurological symptoms began before age 6. It carries a boxed warning for permanent hearing loss.
November 17, 2026 · 3 min read

